TITLE:
Risk Groups and Mortality in Patients with SARS-CoV-2 from Family Medicine Unit No. 43 in Southeastern Mexico
AUTHORS:
Abel Pérez-Pavón, Sigrid Lorena Martínez-Vazquez, Jorge Iván Martínez-Pérez, Jorda Aleiria Albarrán-Melzer, Juan Antonio Córdova-Hernández, Sergio De Jesús Romero-Tapia, Sergio Quiroz-Gomez, Crystell G. Guzmán-Priego
KEYWORDS:
Pandemic, COVID-19, SARS-CoV-2, Hypertension, Diabetes, Obesity, Mortality
JOURNAL NAME:
Journal of Biosciences and Medicines,
Vol.11 No.1,
January
20,
2023
ABSTRACT: SARS-CoV-2 infection is a viral disease that causes respiratory infections that can cause multiple complications. Patients with adjacent morbidities have a higher chance of complications and mortality. The National Health and Nutrition Survey (ENSANUT) in 2018 reported that in Mexico, 75.2% of adults aged 20 years and over are overweight and obese, both situations are closely related to the cases reported as severe COVID and even with a higher risk of mortality. The main objective was to evaluate the risk and mortality groups in patients with SARS-CoV-2 from family medicine in the south of México. The study was carried out during the 2020 year, in the Family Medicine Unit No. 43 of Villahermosa, Tabasco, a cross-sectional, retrospective investigation was carried out with an analytical approach, and the sample was obtained using the formula of n for infinite populations that correspond to 215, patients were included who met the selection criteria; 3 groups were integrated: DM2, HAS and obesity. Descriptive statistics andχ2 formula were used, using the SPSS version 25 Windows program. The female gender presented the highest number of infections 122 (56.7%) and mortality: 5 (2.32%), obesity comorbidity presented the highest number of infections: 194 (90.2%), HAS: 153 (71.2%), and MD: 44 (20.46%). Complications were observed in 23 (10.69%), distributed in: SIRA: 7 (3.3%), multiple organ failure: 6 (2.8%), heart failure: 6 (2.8%) and pneumonia 4 (1.9%). The observed mortality was 8 (3.72%). The comorbidities of patients with the highest mortality were: SAH: 6 (75%) (χ2 = 9.169; df = 1; p = 0.010) and obesity: 6 (75%) (χ2 = 9.169; df = 1; p = 0.010). The group with the highest risk for SARS-CoV-2 was patients with overweight/obesity comorbidities. Mortality was 3.7%. The patients who died had at least one or more comorbidities. The main complications were ARIS, heart failure, and multiple organ failure.